APA (7th ed.) Citation

EO, S., P, W., P, S., MP, M., AA, P., F, H., . . . G, V. (2025). Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms. British journal of haematology, 206(4), 1103. https://doi.org/10.1111/bjh.19895

Chicago Style (17th ed.) Citation

EO, Symes, et al. "Somatic Co-alteration Signatures Are Prognostic in High-grade TP53-mutated Myeloid Neoplasms." British Journal of Haematology 206, no. 4 (2025): 1103. https://doi.org/10.1111/bjh.19895.

MLA (9th ed.) Citation

EO, Symes, et al. "Somatic Co-alteration Signatures Are Prognostic in High-grade TP53-mutated Myeloid Neoplasms." British Journal of Haematology, vol. 206, no. 4, 2025, p. 1103, https://doi.org/10.1111/bjh.19895.